1	[	[	O	(	O	10	DEP	-1
2	Photodynamic	Photodynamic	B-NP	JJ	O	3	NMOD	-1
3	therapy	therapy	I-NP	NN	O	10	DEP	0
4	in	in	B-PP	IN	O	3	NMOD	-1
5	severe	severe	B-NP	JJ	O	9	NMOD	-1
6	chronic	chronic	I-NP	JJ	O	9	NMOD	-1
7	central	central	I-NP	JJ	O	9	NMOD	-1
8	serous	serous	I-NP	JJ	O	9	NMOD	-1
9	chorioretinopaty	chorioretinopaty	I-NP	NN	O	4	PMOD	-1
10	]	]	O	)	O	0	ROOT	-1

1	OBJECTIVE	OBJECTIVE	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	To	To	B-VP	TO	O	4	VMOD	-1
4	determine	determine	I-VP	VB	O	1	NMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	efficacy	efficacy	I-NP	NN	O	4	OBJ	0
7	of	of	B-PP	IN	O	6	NMOD	-1
8	Photodynamic	Photodynamic	B-NP	JJ	O	9	NMOD	-1
9	Therapy	Therapy	I-NP	NN	O	7	PMOD	0
10	(	(	O	(	O	12	DEP	-1
11	PDT	PDT	B-NP	NN	O	12	DEP	0
12	)	)	O	)	O	9	NMOD	-1
13	in	in	B-PP	IN	O	9	NMOD	-1
14	chronic	chronic	B-NP	JJ	O	17	NMOD	-1
15	Central	Central	I-NP	JJ	O	17	NMOD	-1
16	Serous	Serous	I-NP	JJ	O	17	NMOD	-1
17	Chorioretinopathy	Chorioretinopathy	I-NP	NN	O	13	PMOD	-1
18	(	(	O	(	O	20	DEP	-1
19	CSC	CSC	B-NP	NN	B-protein	20	DEP	-1
20	)	)	O	)	O	17	NMOD	-1
21	.	.	O	.	O	4	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Patients	Patient	B-NP	NNS	O	20	SUB	-1
4	diagnosed	diagnose	B-VP	VBN	O	3	NMOD	-1
5	with	with	B-PP	IN	O	4	VMOD	-1
6	chronic	chronic	B-NP	JJ	O	7	NMOD	-1
7	CSC	CSC	I-NP	NNP	O	5	PMOD	-1
8	,	,	O	,	O	3	P	-1
9	with	with	B-PP	IN	O	3	NMOD	-1
10	clinical	clinical	B-NP	JJ	O	11	NMOD	-1
11	evidence	evidence	I-NP	NN	O	9	PMOD	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	activity	activity	B-NP	NN	O	12	PMOD	0
14	and	and	O	CC	O	15	VMOD	-1
15	treated	treat	B-VP	VBN	O	3	NMOD	19	treated
16	with	with	B-PP	IN	O	15	VMOD	-1
17	Photodynamic	Photodynamic	B-NP	JJ	O	18	NMOD	-1
18	Therapy	Therapy	I-NP	NN	O	16	PMOD	0
19	,	,	O	,	O	3	P	-1
20	are	be	B-VP	VBP	O	1	NMOD	-1
21	included	include	I-VP	VBN	O	20	VC	-1
22	in	in	B-PP	IN	O	21	VMOD	-1
23	this	this	B-NP	DT	O	24	NMOD	-1
24	report	report	I-NP	NN	O	22	PMOD	-1
25	.	.	O	.	O	1	P	-1

1	All	All	B-NP	DT	O	2	SUB	-1
2	were	be	B-VP	VBD	O	0	ROOT	-1
3	assessed	assess	I-VP	VBN	O	2	VC	-1
4	by	by	B-PP	IN	O	3	VMOD	-1
5	a	a	B-NP	DT	O	8	NMOD	-1
6	complete	complete	I-NP	JJ	O	8	NMOD	-1
7	ophthalmological	ophthalmological	I-NP	JJ	O	8	NMOD	-1
8	examination	examination	I-NP	NN	O	4	PMOD	-1
9	,	,	O	,	O	3	P	-1
10	including	include	B-PP	VBG	O	3	VMOD	-1
11	assessment	assessment	B-NP	NN	O	10	PMOD	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	the	the	B-NP	DT	O	17	NMOD	-1
14	best	good	I-NP	JJS	O	15	AMOD	-1
15	corrected	correct	I-NP	VBN	O	17	NMOD	-1
16	visual	visual	I-NP	JJ	O	17	NMOD	-1
17	acuity	acuity	I-NP	NN	O	12	PMOD	-1
18	(	(	O	(	O	20	DEP	-1
19	BCVA	BCVA	B-NP	NN	O	20	DEP	-1
20	)	)	O	)	O	17	NMOD	-1
21	using	use	B-VP	VBG	O	2	VMOD	-1
22	an	an	B-NP	DT	O	24	NMOD	-1
23	ETDRS	ETDRS	I-NP	NN	B-protein	24	NMOD	-1
24	chart	chart	I-NP	NN	O	33	NMOD	-1
25	,	,	O	,	O	33	P	-1
26	fluorescein	fluorescein	B-NP	NN	O	33	NMOD	-1
27	and	and	O	CC	O	33	NMOD	-1
28	indocyanine	indocyanine	B-NP	NN	O	29	NMOD	-1
29	angiography	angiography	I-NP	NN	O	33	NMOD	0
30	and	and	O	CC	O	33	NMOD	-1
31	optical	optical	B-NP	JJ	O	33	NMOD	-1
32	coherence	coherence	I-NP	NN	O	33	NMOD	-1
33	tomography	tomography	I-NP	NN	O	21	OBJ	-1
34	(	(	O	(	O	36	DEP	-1
35	OCT	OCT	B-NP	NN	B-DNA	36	DEP	-1
36	)	)	O	)	O	33	NMOD	-1
37	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	main	main	I-NP	JJ	O	3	NMOD	-1
3	objective	objective	I-NP	NN	O	7	SUB	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	study	study	I-NP	NN	O	4	PMOD	-1
7	was	be	B-VP	VBD	O	0	ROOT	-1
8	to	to	B-VP	TO	O	9	VMOD	-1
9	determine	determine	I-VP	VB	O	7	PRD	-1
10	the	the	B-NP	DT	O	14	NMOD	-1
11	mean	mean	I-NP	JJ	O	14	NMOD	-1
12	visual	visual	I-NP	JJ	O	14	NMOD	-1
13	acuity	acuity	I-NP	NN	O	14	NMOD	-1
14	change	change	I-NP	NN	O	9	OBJ	0
15	.	.	O	.	O	7	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	11	11	B-NP	CD	O	4	NMOD	-1
4	eyes	eye	I-NP	NNS	O	8	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	11	11	B-NP	CD	O	7	NMOD	-1
7	patients	patient	I-NP	NNS	O	5	PMOD	-1
8	were	be	B-VP	VBD	O	1	NMOD	-1
9	included	include	I-VP	VBN	O	8	VC	-1
10	in	in	B-PP	IN	O	9	VMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	study	study	I-NP	NN	O	10	PMOD	-1
13	,	,	O	,	O	9	P	-1
14	which	which	B-NP	WDT	O	9	VMOD	-1
15	had	have	B-VP	VBD	O	14	SBAR	-1
16	a	a	B-NP	DT	O	19	NMOD	-1
17	mean	mean	I-NP	JJ	O	18	AMOD	-1
18	follow-up	follow-up	I-NP	JJ	O	19	NMOD	-1
19	period	period	I-NP	NN	O	15	OBJ	-1
20	of	of	B-PP	IN	O	19	NMOD	-1
21	11	11	B-NP	CD	O	22	NMOD	-1
22	months	month	I-NP	NNS	O	20	PMOD	-1
23	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	mean	mean	I-NP	JJ	O	3	NMOD	-1
3	BCVA	BCVA	I-NP	NN	O	4	SUB	-1
4	increased	increase	B-VP	VBD	O	0	ROOT	0
5	from	from	B-PP	IN	O	4	VMOD	-1
6	20/76	20/76	B-NP	CD	O	5	PMOD	-1
7	to	to	B-PP	TO	O	5	PMOD	-1
8	20/64	20/64	B-NP	CD	O	7	PMOD	-1
9	.	.	O	.	O	4	P	-1

1	35	35	B-NP	CD	O	2	NMOD	-1
2	%	%	I-NP	NN	O	5	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	eyes	eye	B-NP	NNS	O	3	PMOD	-1
5	improved	improve	B-VP	VBD	O	0	ROOT	17	improved
6	their	their	B-NP	PRP$	O	7	NMOD	-1
7	BCVA	BCVA	I-NP	NN	B-protein	5	OBJ	-1
8	by	by	B-PP	IN	O	5	VMOD	-1
9	2	2	B-NP	CD	O	10	NMOD	-1
10	lines	line	I-NP	NNS	O	16	SUB	-1
11	or	or	O	CC	O	16	VMOD	-1
12	more	more	B-NP	JJR	O	16	SUB	-1
13	,	,	O	,	O	16	P	-1
14	45	45	B-NP	CD	O	15	NMOD	-1
15	%	%	I-NP	NN	O	16	SUB	-1
16	remained	remain	B-VP	VBD	O	8	SBAR	-1
17	stable	stable	B-ADJP	JJ	O	16	PRD	-1
18	and	and	O	CC	O	16	VMOD	-1
19	18	18	B-NP	CD	O	20	NMOD	-1
20	%	%	I-NP	NN	O	18	PRD	-1
21	lost	lose	B-VP	VBN	O	20	NMOD	-1
22	2	2	B-NP	CD	O	25	NMOD	-1
23	lines	line	I-NP	NNS	O	25	NMOD	-1
24	or	or	I-NP	CC	O	25	NMOD	-1
25	more	more	I-NP	JJR	O	21	AMOD	-1
26	.	.	O	.	O	5	P	-1

1	Choroidal	Choroidal	B-NP	JJ	O	2	NMOD	-1
2	hyperpermeability	hyperpermeability	I-NP	NN	O	3	SUB	-1
3	was	be	B-VP	VBD	O	0	ROOT	-1
4	reduced	reduce	I-VP	VBN	O	3	VC	0
5	in	in	B-PP	IN	O	4	VMOD	-1
6	every	every	B-NP	DT	O	7	NMOD	-1
7	case	case	I-NP	NN	O	5	PMOD	-1
8	.	.	O	.	O	3	P	-1

1	Neurosensorial	Neurosensorial	B-NP	JJ	O	3	NMOD	-1
2	retinal	retinal	I-NP	JJ	O	3	NMOD	-1
3	detachment	detachment	I-NP	NN	O	4	SUB	0
4	decreased	decrease	B-VP	VBD	O	0	ROOT	0
5	in	in	B-PP	IN	O	4	VMOD	-1
6	80	80	B-NP	CD	O	7	NMOD	-1
7	%	%	I-NP	NN	O	5	PMOD	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	cases	case	B-NP	NNS	O	8	PMOD	-1
10	.	.	O	.	O	4	P	-1

1	Only	Only	B-NP	RB	O	3	NMOD	-1
2	one	one	I-NP	CD	O	1	AMOD	-1
3	eye	eye	I-NP	NN	O	4	SUB	-1
4	received	receive	B-VP	VBD	O	0	ROOT	0
5	a	a	B-NP	DT	O	8	NMOD	-1
6	second	second	I-NP	JJ	O	8	NMOD	-1
7	PDT	PDT	I-NP	NN	O	8	NMOD	0
8	treatment	treatment	I-NP	NN	O	4	OBJ	0
9	due	due	B-PP	IN	O	4	VMOD	0
10	to	to	B-PP	TO	O	9	PMOD	-1
11	choroidal	choroidal	B-NP	JJ	O	12	NMOD	-1
12	neovascularization	neovascularization	I-NP	NN	O	10	PMOD	3	neovascularization
13	.	.	O	.	O	4	P	-1

1	An	An	B-NP	DT	O	2	NMOD	-1
2	increase	increase	I-NP	NN	O	13	SUB	17	increase
3	of	of	B-PP	IN	O	2	NMOD	-1
4	atrophy	atrophy	B-NP	NN	O	3	PMOD	-1
5	over	over	B-PP	IN	O	2	NMOD	-1
6	the	the	B-NP	DT	O	9	NMOD	-1
7	Retinal	Retinal	I-NP	JJ	O	9	NMOD	-1
8	Pigment	Pigment	I-NP	NN	O	9	NMOD	-1
9	Epithelium	Epithelium	I-NP	NN	O	5	PMOD	-1
10	(	(	O	(	O	12	DEP	-1
11	RPE	RPE	B-NP	NN	B-protein	12	DEP	-1
12	)	)	O	)	O	9	NMOD	-1
13	was	be	B-VP	VBD	O	0	ROOT	-1
14	observed	observe	I-VP	VBN	O	13	VC	0
15	in	in	B-PP	IN	O	14	VMOD	-1
16	another	another	B-NP	DT	O	17	NMOD	-1
17	patient	patient	I-NP	NN	O	15	PMOD	-1
18	.	.	O	.	O	13	P	-1

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	PDT	PDT	B-NP	NN	O	4	SUB	0
4	can	can	B-VP	MD	O	1	NMOD	-1
5	reduce	reduce	I-VP	VB	O	4	VC	0
6	the	the	B-NP	DT	O	8	NMOD	-1
7	clinical	clinical	I-NP	JJ	O	8	NMOD	-1
8	signs	sign	I-NP	NNS	O	5	OBJ	-1
9	of	of	B-PP	IN	O	8	NMOD	-1
10	activity	activity	B-NP	NN	O	9	PMOD	0
11	,	,	O	,	O	8	P	-1
12	such	such	B-PP	JJ	O	13	PMOD	-1
13	as	as	I-PP	IN	O	8	NMOD	-1
14	choroidal	choroidal	B-NP	JJ	O	15	NMOD	-1
15	hyperpermeability	hyperpermeability	I-NP	NN	O	19	NMOD	-1
16	or	or	O	CC	O	19	NMOD	-1
17	neurosensorial	neurosensorial	B-NP	JJ	O	19	NMOD	-1
18	retinal	retinal	I-NP	JJ	O	19	NMOD	-1
19	detachment	detachment	I-NP	NN	O	13	PMOD	0
20	,	,	O	,	O	5	P	-1
21	in	in	B-PP	IN	O	5	VMOD	-1
22	patients	patient	B-NP	NNS	O	21	PMOD	-1
23	affected	affect	B-VP	VBN	O	22	NMOD	0
24	by	by	B-PP	IN	O	23	VMOD	-1
25	chronic	chronic	B-NP	JJ	O	26	NMOD	-1
26	CSC	CSC	I-NP	NNP	O	24	PMOD	-1
27	.	.	O	.	O	1	P	-1

1	However	However	B-ADVP	RB	O	8	VMOD	-1
2	,	,	O	,	O	8	P	-1
3	the	the	B-NP	DT	O	4	NMOD	-1
4	increase	increase	I-NP	NN	O	8	SUB	0
5	in	in	B-PP	IN	O	4	NMOD	-1
6	visual	visual	B-NP	JJ	O	7	NMOD	-1
7	acuity	acuity	I-NP	NN	O	5	PMOD	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	variable	variable	B-ADJP	JJ	O	8	PRD	-1
10	,	,	O	,	O	8	P	-1
11	probably	probably	B-ADVP	RB	O	8	VMOD	-1
12	due	due	B-ADJP	JJ	O	8	PRD	0
13	to	to	B-PP	TO	O	12	AMOD	-1
14	the	the	B-NP	DT	O	15	NMOD	-1
15	extent	extent	I-NP	NN	O	13	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	RPE	RPE	B-NP	NN	O	18	NMOD	-1
18	damage	damage	I-NP	NN	O	16	PMOD	0
19	.	.	O	.	O	8	P	-1

